Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity.

"Disclosure of potential conflict of interest: The author declares no relevant conflicts of interest."

"S.G.T. is supported by an Investigator Grant awarded by the 10.13039/501100000925National Health and Medical Research Council of Australia, the Allergy & Immunology Foundation of Australia, the Jeffrey Modell Foundation, and a University of New South Wales Sydney COVID Rapid Response Initiative grant. H.C.S. and L.D.N. (listed under the COVID Human Genetic Effort consortium) are supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases, NIH. J.L.C. (listed under the COVID Human Genetic Effort consortium) is supported by the NIH (R01AI088364, R01AI163029, UL1TR001866), Fisher Center for Alzheimer’s Research Foundation, Meyer Foundation, JPB Foundation, French National Research Agency (ANR-10-IAHU-01, ANR-10-LABX-62-IBEID, ANR-20-CE93-003, ANR-20-CO11-0001, French Foundation for Medical Research (EQU201903007798), the ANRS-COV05, European Union’s Horizon 2020 Research and Innovation Program (824110; EASI-genomics), HORIZON-HLTH-2021-DISEASE-04 Program (01057100; UNDINE), the ANR-RHU COVIFERON Program (ANR-21-RHUS-08), the Square Foundation, Grandir - Fonds de solidarité pour l’enfance, the Fondation du Souffle, the SCOR Corporate Foundation for Science, and French Ministry of Higher Education, Research, and Innovation (MESRI-COVID-19)."